Despite not reflecting all aspects of AD pathology, such as tau hyperphosphorylation, β-amyloid deposition, and chronic inflammation, it is still a very useful model for quickly and affordably evaluating memory impairment and the potential therapeutic benefits of different substances, particularly those that are naturally occurring. This evidence concerns the gene MAPT and Alzheimer disease.